共 109 条
[1]
de Souza HS(2016)Immunopathogenesis of IBD: current state of the art Nat Rev Gastroenterol Hepatol 13 13-27
[2]
Fiocchi C(2015)The epidemiology and risk factors of inflammatory bowel disease Int J Clin Exp Med 8 22529-22542
[3]
Ye Y(2012)Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 46-54
[4]
Pang Z(2007)Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey J Crohn’s Colitis 1 10-20
[5]
Chen W(2012)Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements Am J Gastroenterol 107 179-194
[6]
Ju S(2017)Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management J Crohn’s Colitis 11 769-784
[7]
Zhou C(2001)The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study Gastroenterology 121 255-260
[8]
Molodecky NA(1955)Cortisone in ulcerative colitis; final report on a therapeutic trial Br Med J (Clin Res Ed) 2 1041-1048
[9]
Soon IS(1978)A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis Scand J Gastroenterol 13 833-837
[10]
Rabi DM(2011)Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis Am J Gastroenterol 106 590-599